Does regular follow-up influence the survival of patients with sarcoma after recurrence? The miri shitrit pediatric oncology department experience

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 3, 2008, Pages 189-195

  Postovsky, Sergey ^a   Barzilai, Merav ^a   Meller, Itzhak ^c   Kollander, Yehuda ^c   Futerman, Boris ^b   Ben Arush, Myriam Weyl ^a  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b Rambam Health Care Campus   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Follow up; Recurrence; Sarcoma; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BONE SCINTISCANNING; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EWING SARCOMA; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; BONE MARROW EXAMINATION; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISRAEL; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; ONCOLOGY SERVICE, HOSPITAL; OUTCOME ASSESSMENT (HEALTH CARE); POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41849093423     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31815d88fa     Document Type: Article

References (29)

1. Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer. 2006;106:1154-1161.
2. Cecchetto G, Alaggio R, Dall'Igna P, et al. Localized unresectable non-rhabdo soft tissue sarcomas of the extremities in pediatric age: results from the Italian studies. Cancer. 2005;104:2006-2012.
3. Spunt SL, Poquette CA, Hurt YS, et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital. J Clin Oncol. 1999;17:3697-3705.
4. Zogopolos G, Teskey L, Sung L, et al. Ewing sarcoma: favourable results with combined modality therapy and conservative use of radiotherapy. Pediatr Blood Cancer. 2004; 43:35-39.
5. Paulussen M, Ahrens S, Craft AW, et al. Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol. 1998;16:3044-3052.
6. Kager L, Zoubek A, Potschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003;21:2011-2018.
7. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776-790.
8. Ferrari S, Briccoli A, Mercuri M, et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J Clin Oncol. 2003;21:710-715.
9. Barker LM, Pendergrass TW, Sanders LE, et al. Survival after recurrence of Ewing's sarcoma family of tumors. J Clin Oncol. 2005;23:4354-4362.
10. Pappo AS, Anderson JR, Crist WH, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol. 1999;17:3487-3493.
11. Krasin MJ, Rodriguez-Galindo C, Davidoff AM, et al. Efficacy of combined surgery and irradiation for localized Ewing's sarcoma family of tumors. Pediatr Blood Cancer. 2004;43:229-236.
12. Bacci G, Ferrari S, Longhi A, et al. Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery. J Bone Joint Surg Br. 2003;85:107-114.
13. Ferrari S, Smeland S, Mercuri M, et al. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol. 2005;23:8845-8852.
14. Punyko JA, Mertens AC, Baker KS. Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation. Cancer. 2005;103:1475-1483.
15. Korholz D, Verheyen J, Kemperdick HF, et al. Evaluation of follow-up investigations in osteosarcoma patients: suggestions for an effective follow-up program. Med Pediatr Oncol. 1998;30:52-58.
16. Korholz D, Wirtz I, Vosberg H, et al. The role of bone scintigraphy in the follow-up of osteogenic sarcoma. Eur J Cancer. 1996;32A:461-464.
17. Avigad S, Cohen IJ, Zilberstein J, et al. The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer. 2004;100:1053-1058.
18. Brenner DJ, Elliston CD, Hall EJ, et al. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176:289-296.
19. Diederich S, Lenzen H. Radiation exposure associated with imaging of the chest: comparison of different radiographic and computed tomography techniques. Cancer. 2000;89(11 suppl):2457-2460.
20. Atra A, Pinkerton R. High-dose chemotherapy in soft tissue sarcoma in children. Crit Rev Oncol Hematol. 2002;41:191-196.
21. Meyers PA. High-dose therapy with autologous stem cell rescue for pediatric sarcomas. Curr Opin Oncol. 2004;16:120-125.
22. Meyers PA, Krailo MD, Ladanyi M, et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol. 2001;19:2812-2820.
23. Burdach S, Van Kaick B, Laws HJ, et al. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Ann Oncol. 2000;11:1451-1462.
24. Frohlich B, Ahrens S, Burdach S, et al. High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS. Klin Padiatr. 1999;211:284-290.
25. Ben Arush MW, Roguin A, Zamir E, et al. Bleomycin and cyclophosphamide toxicity simulating metastatic nodules to the lungs in childhood cancer. Pediatr Hematol Oncol. 1997;14:547-554.
26. McNeil BJ. Rationale for the use of bone scans in selected metastatic and primary bone tumors. Semin Nucl Med. 1978;8:336-345.
27. Korholz D, Verheyen J, Engelbrecht V, et al. Follow-up of patients with osteosarcoma and Ewing's sarcoma: a retrospective cost-benefit analysis [in German]. Klin Padiatr. 2000;212:220-223.
28. Briccoli A, Rocca M, Salone M, et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer. 2005;104:1721-1725.
29. Harting MT, Huvos AG, Gasher J, et al. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg. 2006;41:194-199.